Two-Vessel Occlusion (2-VO) Model Development Service
Are you currently facing long drug development cycles and challenges in preclinical neurological research? Our two-vessel occlusion (2-VO) models development services help you accelerate neurotherapeutic discovery and obtain high-quality, translatable data through advanced surgical precision and comprehensive mechanistic analysis. We provide robust, reproducible models that streamline your path to identifying effective treatments for global cerebral ischemia.
Global cerebral ischemia poses a significant challenge in neurobiology, leading to widespread neuronal damage and cognitive deficits. The 2-VO model serves as an indispensable preclinical tool, faithfully replicating the diffuse ischemic insult observed in clinical scenarios such as cardiac arrest. By inducing reproducible injury, particularly in vulnerable regions like the hippocampus, the 2-VO model enables deep mechanistic investigations and robust efficacy testing of neuroprotective and neurorestorative compounds, underpinning critical advancements in drug discovery.
How Our 2-VO Models Development Services Can Assist Your Project?
Our 2-VO models development services provide a critical foundation for neuroprotection and neurorestoration studies. We deliver meticulously characterized animal models of global cerebral ischemia, allowing you to confidently evaluate novel therapeutic agents. Our solutions pinpoint efficacy, clarify mechanisms of action, and generate robust data for your regulatory submissions and continued research. Expect precise surgical induction, comprehensive phenotypic characterization, and actionable insights into your compounds' potential.
Discover How We Can Help - Request a Consultation
Workflow: Precision in Preclinical Modeling
Our workflow is designed for clarity, efficiency, and scientific rigor, making the complex process of preclinical modeling transparent and collaborative.
- Required Starting Materials:
Project Proposal/Research Plan: A detailed outline of your research objectives, specific hypotheses, target endpoints, and any preliminary data.
Compound Information: Data sheets for your investigational compounds, including solubility, stability, and proposed dosing regimens.
Regulatory Compliance Documentation: Any relevant ethical approvals or institutional review board (IRB) documents pertaining to your research.
- Final Deliverables:
Comprehensive Study Report: A detailed document summarizing the experimental design, methodologies, raw data, statistical analysis, and clear interpretation of results.
Raw Data Files: All original data files, including behavioral test outputs, histological images, and molecular assay readouts, provided in a user-friendly format.
Customized Presentation: A presentation summarizing key findings and actionable insights, designed for your internal discussions or external stakeholders.
- Estimated Timeframe: The typical timeframe for our 2-VO models development services ranges from 10 to 18 weeks, depending on the complexity of the study design, the number of compounds to be tested, and the scope of the endpoint analyses requested.
Why Choose Us?
Choosing Creative Biolabs for your 2-VO models development needs means partnering with a leader in preclinical neuroscience. Our decades of experience, coupled with a relentless pursuit of scientific excellence, ensure that your projects are handled with the utmost precision and expertise. We are committed to generating high-quality, translatable data that truly advances your neurotherapeutic pipeline.
Experience the Advantage - Get a Quote Today
Customer Reviews:
"Exceptional Data Quality! Using CBL's 2-VO models development services in our research has significantly improved the reproducibility and reliability of our neuroprotective efficacy studies. The histological assessments were incredibly detailed and provided clear evidence of our compound's impact on hippocampal integrity." August 2024, J. Sm***h
"Streamlined Our Research! The comprehensive behavioral analysis provided by CBL's 2-VO services facilitated our understanding of cognitive improvements. Their expertise in Morris Water Maze and NOR testing saved us considerable time and resources, allowing us to focus on downstream molecular mechanisms." July 2024, L. Br***n
"Unmatched Translational Insights! We particularly valued CBL's nuanced approach to addressing species-specific differences and patient heterogeneity within the 2-VO model. This foresight, provided through their services, was crucial in designing our follow-up studies, ensuring our preclinical findings have stronger clinical relevance." September 2024, K. J***s
Two-Vessel Occlusion (2-VO) Models
Global cerebral ischemia, a devastating condition resulting from a transient reduction or cessation of blood flow to the entire brain, is a significant contributor to neurological morbidity and mortality worldwide. Clinically, this can manifest following cardiac arrest, severe hypotension, or major vascular surgery, leading to widespread neuronal damage, particularly in vulnerable regions like the hippocampus, and profound cognitive deficits. The complexity of these conditions necessitates sophisticated and reliable preclinical models to unravel underlying mechanisms and, crucially, to identify effective therapeutic interventions.
The 2-VO model of global cerebral ischemia stands as a cornerstone in this endeavor. By meticulously replicating key pathological hallmarks of human global ischemic events, the 2-VO model provides a powerful platform for rigorous neuroscientific research and drug discovery.
Our service portfolio includes:
| Services | Description |
| Custom 2-VO Model Development & Optimization | Our specialists design and optimize 2-VO models tailored precisely to your experimental objectives, including species/strain selection, ischemia/reperfusion parameters, age/sex matching, and precise surgical induction. |
| Efficacy Assessment for Neuroprotection and Neurorestoration | We provide quantitative analysis of neuronal survival, neuroinflammation profiling, and blood-brain barrier integrity, crucial for evaluating therapeutic potential. |
| Advanced Behavioral and Cognitive Analysis | A suite of validated behavioral tests, including Morris Water Maze, Y-Maze, Radial Arm Maze, Novel Object Recognition, and neurological deficit scoring, to assess cognitive and motor functions. |
| Comprehensive Molecular and Biochemical Analysis | Capabilities include gene expression analysis (qPCR), protein expression analysis (Western blot, ELISA), oxidative stress markers, apoptosis/necrosis markers, and mitochondrial function assays. |
What We Can Offer
At CBL, our 2-VO models development services are designed to provide tailored, high-impact solutions for your unique preclinical research needs. We don't just offer a service; we offer a partnership built on scientific excellence and a commitment to accelerating your discoveries.
- Customized Model Design: We provide fully customizable 2-VO models, precisely tuned to your specific research questions, including adaptable ischemia durations, reperfusion times, and choice of species and strains, ensuring the model perfectly aligns with your therapeutic goals.
- Comprehensive Endpoint Analysis: Our offerings encompass a full spectrum of efficacy endpoints, from detailed histopathological assessments of neuronal survival and damage to advanced molecular and biochemical profiling, giving you a complete picture of your compound's effects.
- Advanced Behavioral & Cognitive Assessment: Leverage our expertise in a wide array of validated behavioral assays, including Morris Water Maze and Novel Object Recognition, to rigorously quantify the functional impact of your interventions on learning, memory, and neurological deficits.
- Translational Expertise & Guidance: With over 20 years of experience, we offer deep insights into enhancing the translational potential of your preclinical findings. We guide you in addressing species-specific differences and patient heterogeneity, making your data more clinically relevant.
- State-of-the-Art Precision: Our services are executed with unparalleled surgical precision and rigorous quality control measures, ensuring high reproducibility and reliability of data – critical for advancing promising drug candidates.
- Integrated Project Management: Benefit from our seamless, one-stop solution that integrates every stage of your project, from initial consultation and experimental design through to detailed data analysis and comprehensive reporting, streamlining your research workflow.
Related Services
To further support your neurological research and drug discovery initiatives, CBL offers a suite of complementary services and model variations:
- Middle Cerebral Artery Occlusion (MCAO) Models
- Spinal Cord Injury Models
- Neuroinflammation & Neurodegeneration Assays
- Pharmacokinetics & Pharmacodynamics (PK/PD) Studies
Ready to advance your neurotherapeutic research with robust preclinical models? Our team of experienced biology specialists is eager to discuss your specific project needs and how our 2-VO models development services can provide the solutions you require.
Contact Our Team for More Information and to Discuss Your Project.
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Rat Muller Cell (Cat#: NCL2110P040)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
